Abstract: A cushioning attachment for shoes including athletic shoes and, in particular, running shoes includes two component features: a cushioning feature, and a resilient/traction feature. In addition, the cushioning attachment can include a securing feature for securing the device to the outsole of the shoe of a wearer In the cushioning attachments, the cushioning feature is typically a first layer of the attachment while the resilient/traction feature is typically a second layer of the attachment. In one aspect, a cushioning attachment has a shape suitable for attaching to the outsole of a shoe and comprises: a. a first upper layer comprising a cushioning material; b. a second lower layer comprising a resilient material; c. a securing means for permanently or removably attaching the cushioning attachment to a shoe. In another aspect, a cushioning attachment for a shoe comprises: a. a first upper layer comprising an anti-fatigue material; b. a second lower layer comprising a wear resistant material; c.

Abstract: A cushioning component for use in shoes including athletic shoes and, for example, running shoes includes a cushioning layer including a first zone and a second zone where the first zone comprises a progressive compression material. In one aspect, the first zone can comprise one or more areas defined within the second zone. For example, the first zone can comprise two areas, one area in a relative front portion of the shoe component and another area in a relative rear portion of the shoe component. Alternatively, in another aspect, the first zone and second zone can be arranged in a laminate-type relationship in the shoe component. In this regard, the first zone can be located either above or below the second zone. The shoe component can be employed as a traditional element of a shoe, such as a midsole or the outsole.

Abstract: A method of treating a non-human dermatological disorder, wherein the method comprises topically administering to a non-human dermatological disorder a therapeutically effective amount of a topical composition containing: (1) an active component comprising at least one salicylate derivative; and (2) at least one pharmaceutically acceptable solubilizer.

Abstract: Topical compositions and methods are disclosed for the treatment of pseudofolliculitis barbae and ingrown hair. The compositions comprise acetylsalicylic acid, propylene glycol, glycerine, and isopropyl alcohol. The method involves the step of applying the composition to the beard areas of the face after shaving. The acetylsalicylic acid is dissolved in a solvent mixture comprising propylene glycol, glycerine, and isopropyl alcohol. The acetylsalicylic acid is present in the range of between about 5 percent by weight per unit volume of the solvent mixture up to saturation of the solvent mixture. The solvent mixture comprises propylene glycol in the range of about 5 to 15 percent by volume, glycerine in the range of about 1 to 10 percent by volume, and the balance of the volume made up with isopropyl alcohol alone or a solution comprising at least 50 percent by volume of isopropyl alcohol.

Abstract: A topical composition for use in a variety of environments includes an active component, e.g., acetylsalicylic acid, a solvent mixture for the active components and, optionally, a silicone additive. The topical compositions according to the invention include nail hardeners, deodorants and sunscreen products.

Abstract: A method of treating a non-human dermatological disorder, wherein the method comprises topically administering to a non-human dermatological disorder a therapeutically effective amount of a topical composition containing: (1) an active component comprising at least one salicylate derivative; and (2) at least one pharmaceutically acceptable solubilizer.

Abstract: A topical composition for use in a variety of environments includes an active component, e.g., acetylsalicylic acid, a solvent mixture for the active components and, optionally, a silicone additive. The topical compositions according to the invention include nail hardeners, deodorants and sunscreen products.

Abstract: Topical compositions and methods are disclosed for the treatment of pseudofolliculitis barbae and ingrown hair. The compositions comprise acetylsalicylic acid, propylene glycol, glycerine, and isopropyl alcohol. The method involves the step of applying the composition to the beard areas of the face after shaving. The acetylsalicylic acid is dissolved in a solvent mixture comprising propylene glycol, glycerine, and isopropyl alcohol. The acetylsalicylic acid is present in the range of between about 5 percent by weight per unit volume of the solvent mixture up to saturation of the solvent mixture. The solvent mixture comprises propylene glycol in the range of about 5 to 15 percent by volume, glycerine in the range of about 1 to 10 percent by volume, and the balance of the volume made up with isopropyl alcohol alone or a solution comprising at least 50 percent by volume of isopropyl alcohol.

Abstract: Topical compositions and methods are disclosed for the treatment of pseudofolliculitis barbae and ingrown hair. The compositions comprise acetylsalicylic acid, propylene glycol, glycerine, and isopropyl alcohol. The method involves the step of applying the composition to the beard areas of the face after shaving. The acetylsalicylic acid is dissolved in a solvent mixture comprising propylene glycol, glycerine, and isopropyl alcohol. The acetylsalicylic acid is present in the range of between about 5 percent by weight per unit volume of the solvent mixture up to saturation of the solvent mixture. The solvent mixture comprises propylene glycol in the range of about 5 to 15 percent by volume, glycerine in the range of about 1 to 10 percent by volume, and the balance of the volume made up with isopropyl alcohol alone or a solution comprising at least 50 percent by volume of isopropyl alcohol.

Abstract: Topical deodorant and compositions are provided. The deodorant compositions include in the range of about 20 to about 80 percent by weight of an acetylsalicylic acid solution and in the range of about 20 to about 80 percent by weight of a waxy carrier. The acetylsalicylic acid solution has acetylsalicylic acid in the range of between about 5 percent by weight per unit volume of a solvent mixture up to saturation of the solvent mixture. This solvent mixture consists essentially of propylene glycol in the range of about 5 to 15 percent by volume, glycerin in the range of about 1 to 10 percent by volume, and the balance of the solvent mixture made up with one or more solvents selected from the group consisting of isopropyl alcohol, water, and ethanol, the balance of the solvent mixture comprising at least 50 percent by volume isopropyl alcohol. The waxy carrier preferably includes cetyl alcohol and sodium stearate.

Abstract: A topical agent and method for the treatment and prevention of pseudofolliculitis barbae, commonly known as "razor bumps", is effected by the topical application to beard areas of the face of a combination of acetylsalicylic acid, corn starch, isopropyl alcohol, and aloe vera.